FDA Delays Final Rule On Allowing Generic Drug Makers To Update Labels
A controversial new rule for updating generic drug labeling that the FDA was expected to finalize next month will not be published until the fall of 2015, an agency spokeswoman says.
The rule, which the FDA proposed last year, would allow generic drug makers to independently update safety warnings, something that only brand-name drug makers can currently do before receiving FDA permission.
Help employers find you! Check out all the jobs and post your resume.
The rule, which the FDA proposed last year, would allow generic drug makers to independently update safety warnings, something that only brand-name drug makers can currently do before receiving FDA permission.
Help employers find you! Check out all the jobs and post your resume.